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EDITORIAL
Withdrawal of long-term antiepileptic treatment in
childrenPerhaps one of the most frequently asked questions
by the parents of children whose seizures are well
controlled, is if—and when—medication can be dis-
continued. Many reasons may prompt this question;
the need to continue taking drugs when the seizures
appear to have stopped, the inconvenience of hav-
ing to take—or give—regular medication even if only
once a day, the development of not only recognized
but also potentially un-recognized side-effects (specif-
ically on concentration, learning and behaviour) and
the emotional and psychological implications of hav-
ing to take medication which contributes to the real (or
perceived) stigmatisation of epilepsy. In contrast, the
reasons for continuing antiepileptic medication may
appear to be less obvious. These include not wish-
ing to ‘rock the boat’ in a child who is seizure-free
and who appears to be functioning well both academ-
ically and socially, the largely unfounded concern that
control may not be re-gained if seizures recur follow-
ing drug withdrawal and the continuing debate as to
whether antiepileptic drug therapy may alter the natu-
ral history of the epilepsy and prevent the development
of chronic epilepsy1.
The question of drug withdrawal is obviously im-
portant and although the decision to stop an anticon-
vulsant may ultimately depend on the personal (in-
cluding emotional) feelings of the parents and the
child, arguments based on medical evidence may have
a role in influencing this decision. Numerous stud-
ies, including the one by Altunbasak et al.15 in this
issue of Seizure have attempted to provide such ev-
idence on which to base the decision to withdraw
antiepileptic drugs in children who have been seizure-
free. These studies have also tried to identify specific
factors which may be associated with an increased
risk of seizure relapse following drug-withdrawal. A
meta-analysis of 25 drug-withdrawal studies involv-
ing 5434 adults and children showed that the overall
seizure relapse rate was 25% at one year and 29% at
two years following withdrawal of an anticonvulsant;
in children, the relapse rate was slightly lower and in
adolescents, slightly higher2. Unfortunately, although1059–1311/99/070381 + 03 $12.00/0a meta-analysis is of academic interest, it is of little
relevance or assistance for the individual clinician or
family.
The current recommended or usual practice is that
drug withdrawal should be considered after a child has
been seizure-free for two years. The source of this rec-
ommendation is unclear but may have originated from
a comment made by Lennox and Lennox in 1960 who
suggested that ‘. . .when from one to three years have
passed without symptoms, the dose may be reduced’3.
Support for this recommendation subsequently came
from a study which showed no difference in the re-
lapse rate (25%) for children who had been seizure-
free for either two or four years, prior to withdrawal
of the anticonvulsant4. However, there is some evi-
dence that a longer period of seizure-freedom may
be associated with a lower relapse rate5. A study of
154 children demonstrated that, two years after with-
drawing their anticonvulsant, 54% were seizure-free in
whom the drug had been discontinued after one year of
seizure-freedom compared with 71% whose drug was
withdrawn after three years of seizure-freedom5. In a
Canadian study of 97 children whose anticonvulsant
had been discontinued after only one year of seizure-
freedom, 61% had remained seizure free at a two-year
follow-up; the authors felt that this figure was sim-
ilar to previous studies in which children had been
seizure-free for longer prior to drug withdrawal6. Fi-
nally, a more recent study suggested that the duration
of seizure-freedom may not necessarily be important
in determining the relapse rate7. In this Dutch prospec-
tive randomized study, 78 children had their anticon-
vulsant withdrawn after six months of being seizure-
free and the remaining 83 children had their drug dis-
continued after one year of seizure-freedom; the re-
lapse rate was almost identical in both groups (51%),
two years after discontinuing the drug7.
Factors which appear to be associated with an
increased risk of relapse are largely predictable—
symptomatic epilepsy (i.e. a definite aetiology), ac-
companying neurological or developmental problems,
multiple seizure types, a long duration of epilepsyc© 1999 BEA Trading Ltd
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The MRC Antiepileptic Drug Withdrawal Study iden-
tified seven prognostic factors, including an abnormal
EEG, which were then used to generate a statistical
model for patients who had been in remission for at
least two years11. Although this model was designed
to be of use in everyday clinical practice, the deter-
mination of the prognostic index and percentage risk
is not that practicable and may be of little relevance
for the vast majority of parents (and teenagers) who
want to know whether they can, or should, stop treat-
ment. A more recent paediatric study has suggested
a prognostic model which could identify children in
whom treatment could be withdrawn after one year of
seizure-freedom12. Many parents either do not under-
stand what a seizure recurrence risk of 90% means,
no matter how simply it is defined, and of those that
do understand, many would consider that this risk is
worth taking if they (or their child) have a 10% chance
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The major deficiency of all these drug-withdrawal
studies, including those which provide predictive or
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to assess relapse rates, or seizure-freedom according
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‘epilepsy’ or, occasionally, seizure types12. This is
somewhat surprising given the relative senescence of
the original ILAE Classification of the epilepsies and
epilepsy syndromes14. Future studies which attempt
to evaluate the rate of seizure relapse and the associ-
ated risk factors following drug withdrawal, must do
so on the basis of the child’s specific epilepsy syn-
drome. This should hopefully provide more meaning-
ful evidence with which to inform the parents of these
children—as well as the children themselves—as to
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have a high relapse rate, it would be clinically use-
ful to identify if there are any specific features of this
syndrome which are not associated with a relapse fol-
lowing drug withdrawal. A similar approach should be
adopted for syndromes which generally have low re-
lapse rates, including childhood-onset typical absence
epilepsy.
However, it is perhaps unrealistic and even some-
what naive to imagine that this approach will be
the major factor in influencing either the parents (or
teenagers with epilepsy), when faced with the opportu-
nity and decision to discontinue treatment. As Lennox
and Lennox commented, ‘Those who advise contin-
uance for life give all credit to the drug and none to
natural healing forces in the body. The frequency with
which seizures stop ‘of their own accord’ discredits
their view. The inconvenience, expense and psycho-
logical dependence of drug-taking should not be con-
tinued unnecessarily. An electrographic examination
may be informative, but actual trial of being without
medicine is the final test’3. For many families, and
teenagers, the opportunity of ‘being without medicine’
may provide the most practical and compelling rea-
son and will frequently militate against scientific argu-
ment when discussing the withdrawal of an antiepilep-
tic drug.
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